Walleye Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-96,627
Closed -$1.69M 4977
2025
Q1
$1.69M Buy
+96,627
New +$1.63M 0.01% 1544
2024
Q4
Sell
-4,219
Closed -$78.5K 5472
2024
Q3
$78.5K Buy
+4,219
New +$71.1K ﹤0.01% 4495
2024
Q2
Sell
-5,559
Closed -$79.4K 5954
2024
Q1
$82.1K Buy
+5,559
New +$77K ﹤0.01% 4490
2023
Q4
Sell
-61,717
Closed -$860K 5445
2023
Q3
$860K Buy
61,717
+51,448
+501% +$658K ﹤0.01% 2370
2023
Q2
$121K Sell
10,269
-15,979
-61% -$182K ﹤0.01% 3359
2023
Q1
$302K Buy
+26,248
New +$325K ﹤0.01% 2116
2022
Q4
Sell
-119,207
Closed -$1.56M 3577
2022
Q3
$1.56M Sell
119,207
-69,300
-37% -$1.02M 0.03% 689
2022
Q2
$2.63M Buy
+188,507
New +$2.52M 0.07% 290
2022
Q1
Sell
-14,787
Closed -$200K 2559
2021
Q4
$200K Sell
14,787
-583,589
-98% -$8.26M 0.01% 1476
2021
Q3
$8.81K Sell
598,376
-117,316
-16% -$1.98M 0.25% 36
2021
Q2
$13K Buy
715,692
+42,764
+6% +$761K 0.44% 15
2021
Q1
$11.7K Buy
672,928
+659,900
+5,065% +$11.6M 0.68% 9
2020
Q4
$226 Buy
+13,028
New +$208K 0.02% 699
2020
Q1
Sell
-5,960
Closed -$127K 1543
2019
Q4
$127K Buy
+5,960
New +$133K 0.01% 1300

Other funds holding SBRA

Walleye Capital's SBRA Position: Q2 2025 in Review

Walleye Capital sold out of Sabra Healthcare REIT (SBRA) in Q2 2025, closing a stake of 96,627 shares — an estimated $1.69M sold.

Walleye Capital first reported a position in SBRA in Q4 2019 and held it in 14 quarters. The position peaked at $2.63M in Q2 2022. 396 funds tracked by Wall St. Rank hold SBRA as of Q2 2025.

  • Walleye Capital reported no remaining Sabra Healthcare REIT position as of Q2 2025 after selling out during the quarter.
  • Walleye Capital sold 96,627 Sabra Healthcare REIT shares in Q2 2025, an estimated $1.69M.
  • Walleye Capital first reported a position in Sabra Healthcare REIT in Q4 2019 and held it in 14 quarters.
  • Walleye Capital's Sabra Healthcare REIT position peaked at $2.63M in Q2 2022.
  • 396 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2025.

Based on Walleye Capital's 13F filing for Q2 2025, filed 13 Aug 2025.